Move Venture Capital
Pre-seed VC writing first checks for founders across the Midwest, with a focus on Nebraska and surrounding states.
Movens Capital
Central European VC investing in tech startups
Moxxie Ventures
Early-stage fund backing exceptional founders building better products
MP Healthcare Venture Management
Corporate venture arm of Mitsubishi Tanabe Pharma, backing seed-stage biotech in neurodegeneration, immunology and rare disease.
MPM BioImpact
Biotech-focused VC and impact fund with 30+ years building and investing in private and public companies across drug development, oncology, and rare disease.
MPower Partners
Japan-based ESG-focused VC backing tech-enabled startups addressing societal challenges, from middle to late stage in Japan and early stage globally.
MS&AD Ventures
Corporate VC backed by MS&AD Insurance Group investing globally in early-stage startups across insurtech, fintech, digital health, AI, and sustainability.
MSD Global Health Innovation Fund
Corporate VC arm of Merck & Co. investing in digital health and data science companies that optimize biopharmaceutical operations and improve patient care.
Mucker Capital
Seed and Series A investor backing founders outside Silicon Valley with hands-on operational support.
Mundi Ventures
Madrid-based global VC backing purpose-driven founders in insurtech, fintech, deeptech, and climate tech across Europe, Latin America, and beyond.
Munich Re Ventures
Munich Re Ventures funds the future of risk for the human endeavor.
Mustard Seed Maze
European impact VC backing pre-seed to Series A ventures where profit and social or environmental outcomes reinforce each other.
Mutschler Ventures
Single-family-office VC investing since 2007, positioning itself as founders' No. 1 follow-on investor for Seed rounds across the DACH region.
Mutual Capital Partners
Backs revenue-stage healthcare IT and medical device companies located outside major tech hubs across the Midwest.
Mutuelles Impact
French mutual-sector impact fund investing in startups and SMEs addressing health, prevention, and social care challenges. Managed by XAnge and Impactivist.
MVM Partners
Global healthcare and life sciences growth equity firm investing $20–100M+ across medical devices, pharma, diagnostics, and digital health.
Myelin VC
Partnering with outliers to build the unimagined and the future
N1
Operator-led early-stage VC investing in AI, healthtech, and frontier tech founders across Europe and the US, from day zero.
N1 Investment Company
European seed-stage VC investing €100K–€350K in tech startups across fintech, edtech, healthtech, legaltech, and SaaS with global scaling ambition.
N49P
Canadian early-stage fund pairing capital with a founder-led community, WhatsApp support, and 50+ operator network access.
Namarel
Barcelona-based early-stage healthcare investor backing medical device, diagnostics, and digital health companies primarily in Spain through pre-seed and seed rounds.
Narya
Early-stage VC partnering with innovators solving future-focused challenges
Nascent VC
Early Stage Venture Capital Firm focussed on opportunities in Latin America.
naturalX Health Ventures
€100M fund investing in consumer health at wellness-medicine intersection
Showing 865–888 of 1406 investors
Get the Complete Healthcare Investor Database
1406 investors · Stages · Sectors · Locations · CSV + Excel
Get all 1406 investors →